Clinical Trial Update: Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma [Phase 2]

View source ↗

Summary

A Phase 2 trial investigating AKB-9778 ophthalmic solution as an adjunct to latanoprost in ocular hypertension or primary open-angle glaucoma has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• AKB-9778 ophthalmic solution (AKB-9778)
• Latanoprost (Latanoprost)

Snippet

Sponsor: EyePoint Pharmaceuticals, Inc. | Conditions: Ocular Hypertension, Primary Open Angle Glaucoma | Phase 2 | Status: COMPLETED | Results posted: 2023-05-25